{"title": "Inmunidad entrenada: La memoria inmune innata como alternativa frente al COVID-19", "author": "Grupo de Investigaci\u00f3n en Inmunolog\u00eda y Virolog\u00eda", "url": "https://grupoinmunovirologia.medium.com/inmunidad-entrenada-covid-19-5d506b54c54b", "hostname": "medium.com", "description": "En las \u00faltimas d\u00e9cadas, importantes descubrimientos han cambiado la forma en que vemos el sistema inmune innato. Caracter\u00edsticas como la\u2026", "sitename": "Medium", "date": "2020-09-21", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Inmunidad entrenada: La memoria inmune innata como alternativa frente al COVID-19\nEn las \u00faltimas d\u00e9cadas, importantes descubrimientos han cambiado la forma en que vemos el sistema inmune innato. Caracter\u00edsticas como la especificidad y la memoria que se atribuyen al sistema inmune adaptativo (c\u00e9lulas T y B), ahora tambi\u00e9n se consideran parte del sistema inmune innato. Tras diversas observaciones en animales y humanos, en 2011, Netea et al.\n[(1)](https://doi.org/10.1016/j.chom.2011.04.006) denominaron a esta propiedad de construcci\u00f3n funcional similar de memoria inmune como \u201cinmunidad entrenada\u201d, defini\u00e9ndola como una respuesta inmune innata mejorada a diferentes pat\u00f3genos despu\u00e9s de un desaf\u00edo inicial, que puede ser una vacuna o una infecci\u00f3n [(2)](https://doi.org/10.1016/j.cell.2020.04.042).\nEl \u201cfenotipo entrenado\u201d, fue observado por primera vez en monocitos/macr\u00f3fagos y c\u00e9lulas NK, sin embargo, con el avance de las investigaciones, este comportamiento tambi\u00e9n se observ\u00f3 en c\u00e9lulas no inmunes (c\u00e9lulas madre hematopoy\u00e9ticas, c\u00e9lulas del estroma y c\u00e9lulas madre mesenquimales)\n[(3)](https://doi.org/10.3389/fmicb.2018.03225) y desde entonces, un n\u00famero creciente de estudios, ha evaluado el rol de la inmunidad entrenada en la homeostasis y la enfermedad [(4)](https://doi.org/10.3389/fphar.2020.01050).\nLos mecanismos que subyacen a la inmunidad entrenada no se han dilucidado por completo. Sin embargo, para que las c\u00e9lulas inmunes innatas adquieran el estado entrenado, ciertos componentes microbianos (los lipopolisac\u00e1ridos, el ADN bacteriano, los mananos), f\u00fangicos (\u03b2-glucanos) y vacunas con adyuvante, deben ser reconocidos primero por los receptores de reconocimiento de patrones (PRR) espec\u00edficos e inducir cambios metab\u00f3licos y epigen\u00e9ticos duraderos en estas c\u00e9lulas, que les permita actuar de manera eficiente durante una segunda infecci\u00f3n.\nDurante la inducci\u00f3n de la inmunidad entrenada, las c\u00e9lulas inmunes innatas, experimentan cambios en el metabolismo celular. La inmunidad entrenada induce diferentes v\u00edas metab\u00f3licas (s\u00edntesis del colesterol, metabolismo de amino\u00e1cidos), pero la m\u00e1s estudiada, es la v\u00eda glucol\u00edtica. El aumento del consumo de glucosa con la producci\u00f3n de lactato y disminuci\u00f3n de la fosforilaci\u00f3n oxidativa, es esencial para la inducci\u00f3n del \u201cfenotipo entrenado\u201d en monocitos/macrofagos\n[(5)](https://doi.org/10.1155/2015/478408). Todav\u00eda no est\u00e1 claro c\u00f3mo la inducci\u00f3n de la gluc\u00f3lisis conduce exactamente a cambios epigen\u00e9ticos en la arquitectura de la cromatina, pero se sugiere que la acumulaci\u00f3n de acetil-CoA produce la acetilaci\u00f3n de las histonas [(6)](https://doi.org/10.3389/fimmu.2018.00298), cuya modificaci\u00f3n, permite un acceso m\u00e1s r\u00e1pido de los factores de transcripci\u00f3n a las regiones promotoras y potenciadoras de genes proinflamatorios que codifican citocinas como IL-6, TNF-\u03b1 e IFN-\u03b3, que desempe\u00f1an un papel fundamental en la supresi\u00f3n de pat\u00f3genos no relacionados ( [4](https://doi.org/10.3389/fphar.2020.01050), [7](https://doi.org/10.3389/fimmu.2018.02869), [8](https://doi.org/10.3389/fimmu.2020.00970)), tras una segunda estimulaci\u00f3n.\nAdem\u00e1s de la reprogramaci\u00f3n metab\u00f3lica y epigen\u00e9tica, existen otros mecanismos supuestamente implicados en el establecimiento de la memoria inmune innata, que incluyen la participaci\u00f3n de diferentes subpoblaciones de monocitos ( CD16 + , CD14 + CD16 -) y una mayor expresi\u00f3n del PRR en la membrana celular por ejemplo despu\u00e9s de la vacunaci\u00f3n con BCG\n[(5)](https://doi.org/10.1155/2015/478408).\nTeniendo en cuenta la urgencia de mejorar la respuesta inmune de la poblaci\u00f3n frente al COVID-19, se plantea un enfoque potencial para lograr este objetivo, que consiste en inducir inmunidad entrenada por vacunaci\u00f3n\n[(9)](https://doi.org/10.1038/nri.2016.43). De esta manera, vacunas como la BCG, polio, sarampi\u00f3n, viruela, Poly-ICLC [(10)](https://doi.org/10.1016/j.antiviral.2016.12.007), pueden representar una herramienta importante para reducir la susceptibilidad y la gravedad de la enfermedad por el SARS-CoV-2, a pesar de tener un efecto \u201cheter\u00f3logo\u201d contra pat\u00f3genos no relacionados ( [9](https://doi.org/10.1038/nri.2016.43), [11](https://doi.org/10.1016/j.cmi.2019.04.020)).\nAunque no hay v\u00ednculo directo entre la inmunizaci\u00f3n con BCG y SARS-CoV-2, la evidencia disponible ha revelado los efectos beneficiosos (no espec\u00edficos) de la vacuna, que incluyen, reducci\u00f3n en la mortalidad infantil\n[(12)](https://doi.org/10.1136/bmj.i5170), protecci\u00f3n contra ciertos carcinomas [(13)](https://doi.org/10.1038/nrurol.2014.15) y la inducci\u00f3n de \u201cinmunidad entrenada\u201d protectora contra pat\u00f3genos no relacionados, como Staphylococcus aureus, Candida albicans [(14)](https://doi.org/10.1016/j.chom.2017.12.010), virus de la fiebre amarilla [(14)](https://doi.org/10.1016/j.chom.2017.12.010), virus sincitial respiratorio [(15)](https://doi.org/10.1016/j.vaccine.2004.09.006), virus vaccinia, virus del herpes simple [(16)](https://doi.org/10.3181%2F00379727-152-39327), virus del papiloma humano [(14)](https://doi.org/10.1016/j.chom.2017.12.010), virus Influenza A (H1N1) [(17)](https://doi.org/10.1093/infdis/jiv332), entre otros.\nLa inmunizaci\u00f3n con BCG entrena las c\u00e9lulas inmunes innatas, para una mejor producci\u00f3n de citocinas proinflamatorias como IFN-\u03b3, TNF- \u03b1, IL-1\u03b2, IL-10 e IL-12, despu\u00e9s de una segunda estimulaci\u00f3n\n[(18)](https://doi.org/10.1016/j.euo.2020.04.001). Sin embargo, es necesario saber cu\u00e1l es el momento oportuno para utilizarla. Netea et al [(2)](https://doi.org/10.1016/j.cell.2020.04.042), proponen que la inducci\u00f3n de inmunidad entrenada por BCG debe realizarse en individuos sanos, ya que refuerza los mecanismos antimicrobianos innatos, que conduce a una eliminaci\u00f3n viral m\u00e1s r\u00e1pida. Por otra parte, tambi\u00e9n es necesario conocer sus efectos perjudiciales en el mantenimiento de la enfermedad si se induce o activa de manera inapropiada ( [2](https://doi.org/10.1016/j.cell.2020.04.042), [9](https://doi.org/10.1038/nri.2016.43)). Para ello, se necesita de ensayos aleatorios controlados, primero en poblaciones con alto riesgo de infecci\u00f3n (personal hospitalario, personas de edad avanzada, infantes y pacientes con comorbilidades) que permitan una identificaci\u00f3n m\u00e1s r\u00e1pida de los resultados beneficiosos en el SARS-CoV-2.\nEl nuevo concepto de \u201cinmunidad entrenada\u201c representa un cambio en la biolog\u00eda de la inmunidad. La evidencia emergente, sobre las propiedades de que las c\u00e9lulas inmunes innatas pueden construir memoria inmune, est\u00e1 cambiando nuestra comprensi\u00f3n de la defensa del hu\u00e9sped, sin embargo, la identificaci\u00f3n en profundidad de los mecanismos moleculares y celulares implicados, y duraci\u00f3n de protecci\u00f3n proporcionada, deja cuestiones abiertas que los estudios futuros deben abordar.\nEl enfoque de vacunaci\u00f3n que utiliza inmunidad entrenada, incluso si tiene \u00e9xito, s\u00f3lo proporcionar\u00e1 protecci\u00f3n parcial durante un per\u00edodo de tiempo limitado. Por lo tanto, la inducci\u00f3n de inmunidad entrenada, si bien es \u00fatil, es solo un puente hacia el desarrollo de una vacuna espec\u00edfica contra el SARS-CoV-2\n[(2)](https://doi.org/10.1016/j.cell.2020.04.042).\nAutor: Danny O. Suclupe Campos\nORCID:\n[https://orcid.org/0000-0003-4930-3689](https://orcid.org/0000-0003-4930-3689)\nMicrobi\u00f3logo. Universidad Pedro Ru\u00edz Gallo. Facultad de Ciencias Biol\u00f3gicas, Departamento De Microbiolog\u00eda. Lambayeque, Per\u00fa.\nReferencias\n1. Netea MG, Quintin J, van der Meer JWM. Trained Immunity: A Memory for Innate Host Defense. Cell Host Microbe [Internet]. 2011;9(5):355\u201361. Disponible en:\n[https://doi.org/10.1016/j.chom.2011.04.006](https://doi.org/10.1016/j.chom.2011.04.006)\n2. Netea MG, Giamarellos-Bourboulis EJ, Dom\u00ednguez-Andr\u00e9s J, Curtis N, van Crevel R, van de Veerdonk FL, et al. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection. Cell [Internet]. 2020;181(5):969\u201377. Disponible en:\n[https://doi.org/10.1016/j.cell.2020.04.042](https://doi.org/10.1016/j.cell.2020.04.042)\n3. Hamada A, Torre C, Drancourt M, Ghigo E. Trained Immunity Carried by Non-immune Cells. Front Microbiol [Internet]. 2019;9. Disponible en:\n[https://doi.org/10.3389/fmicb.2018.03225](https://doi.org/10.3389/fmicb.2018.03225)\n4. Kamat S, Kumari M. BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? Front Pharmacol [Internet]. 2020;11. Disponible en:\n[https://doi.org/10.3389/fphar.2020.01050](https://doi.org/10.3389/fphar.2020.01050)\n5. T\u00f6pfer E, Boraschi D, Italiani P. Innate Immune Memory: The Latest Frontier of Adjuvanticity. J Immunol Res [Internet]. 2015;2015:1\u20137. Disponible en:\n[https://doi.org/10.1155/2015/478408](https://doi.org/10.1155/2015/478408)\n6. Arts RJW, Joosten LAB, Netea MG. The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders. Front Immunol [Internet]. 2018;9. Disponible en:\n[https://doi.org/10.3389/fimmu.2018.00298](https://doi.org/10.3389/fimmu.2018.00298)\n7. Uthayakumar D, Paris S, Chapat L, Freyburger L, Poulet H, De Luca K. Non-specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations. Front Immunol [Internet]. 2018;9. Disponible en:\n[https://doi.org/10.3389/fimmu.2018.02869](https://doi.org/10.3389/fimmu.2018.02869)\n8. Covi\u00e1n C, Retamal-D\u00edaz A, Bueno SM, Kalergis AM. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2? Front Immunol [Internet]. 2020;11. Disponible en:\n[https://doi.org/10.3389/fimmu.2020.00970](https://doi.org/10.3389/fimmu.2020.00970)\n9. Goodridge HS, Ahmed SS, Curtis N, Kollmann TR, Levy O, Netea MG, et al. Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol [Internet]. 2016;16(6):392\u2013400. Disponible en:\n[https://doi.org/10.1038/nri.2016.43](https://doi.org/10.1038/nri.2016.43)\n10. Kumaki Y, Salazar AM, Wandersee MK, Barnard DL. Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol\u00ae (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model. Antiviral Res [Internet]. 2017;139:1\u201312. Disponible en:\n[https://doi.org/10.1016/j.antiviral.2016.12.007](https://doi.org/10.1016/j.antiviral.2016.12.007)\n11. Moorlag SJCFM, Arts RJW, van Crevel R, Netea MG. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect [Internet]. 2019;25(12):1473\u20138. Disponible en:\n[https://doi.org/10.1016/j.cmi.2019.04.020](https://doi.org/10.1016/j.cmi.2019.04.020)\n12. Higgins JPT, Soares-Weiser K, L\u00f3pez-L\u00f3pez JA, Kakourou A, Chaplin K, Christensen H, et al. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ [Internet]. 2016;i5170. Disponible en:\n[https://doi.org/10.1136/bmj.i5170](https://doi.org/10.1136/bmj.i5170)\n13. Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer \u2014 a current perspective. Nat Rev Urol [Internet]. 2014;11(3):153\u201362. Disponible en:\n[https://doi.org/10.1038/nrurol.2014.15](https://doi.org/10.1038/nrurol.2014.15)\n14. Arts RJW, Moorlag SJCFM, Novakovic B, Li Y, Wang S-Y, Oosting M, et al. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe [Internet]. enero de 2018;23(1):89\u2013100.e5. Disponible en:\n[https://doi.org/10.1016/j.chom.2017.12.010](https://doi.org/10.1016/j.chom.2017.12.010)\n15. Stensballe LG, Nante E, Jensen IP, Kofoed P-E, Poulsen A, Jensen H, et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls. Vaccine [Internet]. 2005;23(10):1251\u20137. Disponible en:\n[https://doi.org/10.1016/j.vaccine.2004.09.006](https://doi.org/10.1016/j.vaccine.2004.09.006)\n16. Starr SE, Visintine AM, Tomeh MO, Nahmias AJ. Effects of Immunostimulants on Resistance of Newborn Mice to Herpes Simplex Type 2 Infection. Exp Biol Med [Internet]. 1976;152(1):57\u201360. Disponible en:\n[https://doi.org/10.3181%2F00379727-152-39327](https://doi.org/10.3181%2F00379727-152-39327)\n17. Leentjens J, Kox M, Stokman R, Gerretsen J, Diavatopoulos DA, van Crevel R, et al. BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study. J Infect Dis [Internet]. 2015;212(12):1930\u20138. Disponible en:\n[https://doi.org/10.1093/infdis/jiv332](https://doi.org/10.1093/infdis/jiv332)\n18. Hegarty PK, Sfakianos JP, Giannarini G, DiNardo AR, Kamat AM. COVID-19 y Bacillus Calmette-Gu\u00e9rin: \u00bfCu\u00e1l es el v\u00ednculo? Eur Urol Oncol [Internet]. junio de 2020; 3 (3): 259\u201361. Disponible en:\n[https://doi.org/10.1016/j.euo.2020.04.001](https://doi.org/10.1016/j.euo.2020.04.001)", "language": null, "image": "https://miro.medium.com/v2/resize:fit:1200/1*i621TGmpFjzwEBSWibS39A.jpeg", "pagetype": "article", "links": ["https://medium.com/?source=---two_column_layout_nav----------------------------------", "/?source=post_page-----5d506b54c54b--------------------------------", "/?source=post_page-----5d506b54c54b--------------------------------", "https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fsubscribe%2Fuser%2F2c5cd3d0d36c&operation=register&redirect=https%3A%2F%2Fgrupoinmunovirologia.medium.com%2Finmunidad-entrenada-covid-19-5d506b54c54b&user=Grupo+de+Investigaci%C3%B3n+en+Inmunolog%C3%ADa+y+Virolog%C3%ADa&userId=2c5cd3d0d36c&source=post_page-2c5cd3d0d36c----5d506b54c54b---------------------post_header-----------", "https://doi.org/10.1016/j.chom.2011.04.006", "https://doi.org/10.1016/j.cell.2020.04.042", "https://doi.org/10.3389/fmicb.2018.03225", "https://doi.org/10.3389/fphar.2020.01050", "https://doi.org/10.1155/2015/478408", "https://doi.org/10.3389/fimmu.2018.00298", "https://doi.org/10.3389/fphar.2020.01050", "https://doi.org/10.3389/fimmu.2018.02869", "https://doi.org/10.3389/fimmu.2020.00970", "https://doi.org/10.1155/2015/478408", "https://doi.org/10.1016/j.cell.2020.04.042", "https://doi.org/10.1038/nri.2016.43", "https://doi.org/10.1016/j.antiviral.2016.12.007", "https://doi.org/10.1038/nri.2016.43", "https://doi.org/10.1016/j.cmi.2019.04.020", "https://doi.org/10.1136/bmj.i5170", "https://doi.org/10.1038/nrurol.2014.15", "https://doi.org/10.1016/j.chom.2017.12.010", "https://doi.org/10.1016/j.chom.2017.12.010", "https://doi.org/10.1016/j.vaccine.2004.09.006", "https://doi.org/10.3181%2F00379727-152-39327", "https://doi.org/10.1016/j.chom.2017.12.010", "https://doi.org/10.1093/infdis/jiv332", "https://doi.org/10.1016/j.euo.2020.04.001", "https://doi.org/10.1016/j.cell.2020.04.042", "https://doi.org/10.1016/j.cell.2020.04.042", "https://doi.org/10.1038/nri.2016.43", "https://doi.org/10.1016/j.cell.2020.04.042", "https://doi.org/10.1016/j.cell.2020.04.042", "https://orcid.org/0000-0003-4930-3689", "https://doi.org/10.1016/j.chom.2011.04.006", "https://doi.org/10.1016/j.cell.2020.04.042", "https://doi.org/10.3389/fmicb.2018.03225", "https://doi.org/10.3389/fphar.2020.01050", "https://doi.org/10.1155/2015/478408", "https://doi.org/10.3389/fimmu.2018.00298", "https://doi.org/10.3389/fimmu.2018.02869", "https://doi.org/10.3389/fimmu.2020.00970", "https://doi.org/10.1038/nri.2016.43", "https://doi.org/10.1016/j.antiviral.2016.12.007", "https://doi.org/10.1016/j.cmi.2019.04.020", "https://doi.org/10.1136/bmj.i5170", "https://doi.org/10.1038/nrurol.2014.15", "https://doi.org/10.1016/j.chom.2017.12.010", "https://doi.org/10.1016/j.vaccine.2004.09.006", "https://doi.org/10.3181%2F00379727-152-39327", "https://doi.org/10.1093/infdis/jiv332", "https://doi.org/10.1016/j.euo.2020.04.001", "https://medium.com/tag/covid-19?source=post_page-----5d506b54c54b---------------covid_19-----------------", "https://medium.com/tag/vaccines?source=post_page-----5d506b54c54b---------------vaccines-----------------", "https://medium.com/tag/immunity?source=post_page-----5d506b54c54b---------------immunity-----------------", "https://medium.com/tag/bcg-vaccine?source=post_page-----5d506b54c54b---------------bcg_vaccine-----------------", "https://medium.com/tag/sars-cov2?source=post_page-----5d506b54c54b---------------sars_cov2-----------------", "/?source=post_page-----5d506b54c54b--------------------------------", "https://medium.com/m/signin?actionUrl=%2F_%2Fapi%2Fusers%2F2c5cd3d0d36c%2Flazily-enable-writer-subscription&operation=register&redirect=https%3A%2F%2Fgrupoinmunovirologia.medium.com%2Finmunidad-entrenada-covid-19-5d506b54c54b&user=Grupo+de+Investigaci%C3%B3n+en+Inmunolog%C3%ADa+y+Virolog%C3%ADa&userId=2c5cd3d0d36c&source=-----5d506b54c54b---------------------subscribe_user-----------", "/?source=post_page-----5d506b54c54b--------------------------------", "/followers?source=post_page-----5d506b54c54b--------------------------------", "https://medium.com/m/signin?actionUrl=%2F_%2Fapi%2Fusers%2F2c5cd3d0d36c%2Flazily-enable-writer-subscription&operation=register&redirect=https%3A%2F%2Fgrupoinmunovirologia.medium.com%2Finmunidad-entrenada-covid-19-5d506b54c54b&user=Grupo+de+Investigaci%C3%B3n+en+Inmunolog%C3%ADa+y+Virolog%C3%ADa&userId=2c5cd3d0d36c&source=-----5d506b54c54b---------------------subscribe_user-----------", "/microbioma-infecciones-virales-cac731ef512e?source=author_recirc-----5d506b54c54b----0---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/?source=author_recirc-----5d506b54c54b----0---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/?source=author_recirc-----5d506b54c54b----0---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/microbioma-infecciones-virales-cac731ef512e?source=author_recirc-----5d506b54c54b----0---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/microbioma-infecciones-virales-cac731ef512e?source=author_recirc-----5d506b54c54b----0---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/microbioma-infecciones-virales-cac731ef512e?responsesOpen=true&sortBy=REVERSE_CHRON&source=author_recirc-----5d506b54c54b----0---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/el-virus-sarampi\u00f3n-2020-3769a988c366?source=author_recirc-----5d506b54c54b----1---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/?source=author_recirc-----5d506b54c54b----1---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/?source=author_recirc-----5d506b54c54b----1---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/el-virus-sarampi\u00f3n-2020-3769a988c366?source=author_recirc-----5d506b54c54b----1---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/el-virus-sarampi\u00f3n-2020-3769a988c366?source=author_recirc-----5d506b54c54b----1---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/el-virus-sarampi\u00f3n-2020-3769a988c366?responsesOpen=true&sortBy=REVERSE_CHRON&source=author_recirc-----5d506b54c54b----1---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/coinfecci\u00f3n-viral-covid-19-4181275c1c45?source=author_recirc-----5d506b54c54b----2---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/?source=author_recirc-----5d506b54c54b----2---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/?source=author_recirc-----5d506b54c54b----2---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/coinfecci\u00f3n-viral-covid-19-4181275c1c45?source=author_recirc-----5d506b54c54b----2---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/coinfecci\u00f3n-viral-covid-19-4181275c1c45?source=author_recirc-----5d506b54c54b----2---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/coinfecci\u00f3n-viral-covid-19-4181275c1c45?responsesOpen=true&sortBy=REVERSE_CHRON&source=author_recirc-----5d506b54c54b----2---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/fagoterapia-bacterias-multirresistentes-bc8037e69948?source=author_recirc-----5d506b54c54b----3---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/?source=author_recirc-----5d506b54c54b----3---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/?source=author_recirc-----5d506b54c54b----3---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/fagoterapia-bacterias-multirresistentes-bc8037e69948?source=author_recirc-----5d506b54c54b----3---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/fagoterapia-bacterias-multirresistentes-bc8037e69948?source=author_recirc-----5d506b54c54b----3---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/fagoterapia-bacterias-multirresistentes-bc8037e69948?responsesOpen=true&sortBy=REVERSE_CHRON&source=author_recirc-----5d506b54c54b----3---------------------eff5707e_1a0a_4f6d_9e8f_2835c0c946a0-------", "/?source=post_page-----5d506b54c54b--------------------------------", "https://medium.com/@UnbecomingStories/10-seconds-that-ended-my-20-year-marriage-a6f367f02e53?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@UnbecomingStories?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@UnbecomingStories?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@UnbecomingStories/10-seconds-that-ended-my-20-year-marriage-a6f367f02e53?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@UnbecomingStories/10-seconds-that-ended-my-20-year-marriage-a6f367f02e53?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@UnbecomingStories/10-seconds-that-ended-my-20-year-marriage-a6f367f02e53?responsesOpen=true&sortBy=REVERSE_CHRON&source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://entreprenal.com/the-chatgpt-hype-is-over-now-watch-how-google-will-kill-chatgpt-426d5e3f7d05?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://entreprenal.com/?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://entreprenal.com/?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://entreprenal.com/the-chatgpt-hype-is-over-now-watch-how-google-will-kill-chatgpt-426d5e3f7d05?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://entreprenal.com/the-chatgpt-hype-is-over-now-watch-how-google-will-kill-chatgpt-426d5e3f7d05?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://entreprenal.com/the-chatgpt-hype-is-over-now-watch-how-google-will-kill-chatgpt-426d5e3f7d05?responsesOpen=true&sortBy=REVERSE_CHRON&source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "/list/6-sciencebacked-health-stories-on-covid-sleep-and-more-37b99999b8f6?source=read_next_recirc-----5d506b54c54b--------------------------------", "/list/living-well-as-a-neurodivergent-person-e830014a1893?source=read_next_recirc-----5d506b54c54b--------------------------------", "/list/staff-picks-c7bc6e1ee00f?source=read_next_recirc-----5d506b54c54b--------------------------------", "/list/interesting-design-topics-7d81aee45544?source=read_next_recirc-----5d506b54c54b--------------------------------", "https://medium.com/@73srabt/bye-bye-spotify-37bb823839d2?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@73srabt?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@73srabt?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/pitfall?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@73srabt/bye-bye-spotify-37bb823839d2?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@73srabt/bye-bye-spotify-37bb823839d2?source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@73srabt/bye-bye-spotify-37bb823839d2?responsesOpen=true&sortBy=REVERSE_CHRON&source=read_next_recirc-----5d506b54c54b----0---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@mirijam.missbichler/why-japanese-websites-look-so-different-2c7273e8be1e?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@mirijam.missbichler?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@mirijam.missbichler?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@mirijam.missbichler/why-japanese-websites-look-so-different-2c7273e8be1e?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@mirijam.missbichler/why-japanese-websites-look-so-different-2c7273e8be1e?source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/@mirijam.missbichler/why-japanese-websites-look-so-different-2c7273e8be1e?responsesOpen=true&sortBy=REVERSE_CHRON&source=read_next_recirc-----5d506b54c54b----1---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://nickfthilton.medium.com/the-end-of-the-subscription-era-is-coming-ed197f252c6a?source=read_next_recirc-----5d506b54c54b----2---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://nickfthilton.medium.com/?source=read_next_recirc-----5d506b54c54b----2---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://nickfthilton.medium.com/?source=read_next_recirc-----5d506b54c54b----2---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://nickfthilton.medium.com/the-end-of-the-subscription-era-is-coming-ed197f252c6a?source=read_next_recirc-----5d506b54c54b----2---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://nickfthilton.medium.com/the-end-of-the-subscription-era-is-coming-ed197f252c6a?source=read_next_recirc-----5d506b54c54b----2---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://nickfthilton.medium.com/the-end-of-the-subscription-era-is-coming-ed197f252c6a?responsesOpen=true&sortBy=REVERSE_CHRON&source=read_next_recirc-----5d506b54c54b----2---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://wlockett.medium.com/tesla-should-be-worried-about-toyota-7611a68a583b?source=read_next_recirc-----5d506b54c54b----3---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://wlockett.medium.com/?source=read_next_recirc-----5d506b54c54b----3---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://wlockett.medium.com/?source=read_next_recirc-----5d506b54c54b----3---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/predict?source=read_next_recirc-----5d506b54c54b----3---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://wlockett.medium.com/tesla-should-be-worried-about-toyota-7611a68a583b?source=read_next_recirc-----5d506b54c54b----3---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://wlockett.medium.com/tesla-should-be-worried-about-toyota-7611a68a583b?source=read_next_recirc-----5d506b54c54b----3---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://wlockett.medium.com/tesla-should-be-worried-about-toyota-7611a68a583b?responsesOpen=true&sortBy=REVERSE_CHRON&source=read_next_recirc-----5d506b54c54b----3---------------------c6c25e95_d378_4923_be4b_ccb715bdfd9a-------", "https://medium.com/?source=post_page-----5d506b54c54b--------------------------------", "https://help.medium.com/hc/en-us?source=post_page-----5d506b54c54b--------------------------------", "https://medium.statuspage.io/?source=post_page-----5d506b54c54b--------------------------------", "https://about.medium.com/creators/?source=post_page-----5d506b54c54b--------------------------------", "https://blog.medium.com/?source=post_page-----5d506b54c54b--------------------------------", "https://medium.com/jobs-at-medium/work-at-medium-959d1a85284e?source=post_page-----5d506b54c54b--------------------------------", "https://policy.medium.com/medium-privacy-policy-f03bf92035c9?source=post_page-----5d506b54c54b--------------------------------", "https://policy.medium.com/medium-terms-of-service-9db0094a1e0f?source=post_page-----5d506b54c54b--------------------------------", "https://medium.com/about?autoplay=1&source=post_page-----5d506b54c54b--------------------------------", "https://speechify.com/medium?source=post_page-----5d506b54c54b--------------------------------", "https://medium.com/business?source=post_page-----5d506b54c54b--------------------------------"]}